Table 1 Baseline demographic and clinical characteristics of study participants
Group | n | Gender (Male/Female) | Age (Years, Mean ± SD) | BMI (kg/m², Mean ± SD) | Statistical Test (χ² or F) | P-Value |
|---|---|---|---|---|---|---|
Control Group | 50 | 26/24 | 50.84 ± 2.97 | 23.53 ± 2.83 | χ² = 0.448; F = 0.424 | 0.930; 0.736 |
Mild EGV Group | 71 | 41/30 | 50.70 ± 2.70 | 23.89 ± 2.86 | χ² = 0.448; F = 0.424 | 0.930; 0.736 |
Moderate EGV Group | 40 | 23/17 | 50.98 ± 2.67 | 23.62 ± 2.83 | χ² = 0.448; F = 0.424 | 0.930; 0.736 |
Severe EGV Group | 25 | 14/11 | 51.44 ± 3.36 | 23.33 ± 2.84 | χ² = 0.448; F = 0.424 | 0.930; 0.736 |